>
Leaked phone call confirms the WNBA is in deep sh*t…
Why Not Just Admit It? The Welfare-Warfare State Has Failed.
700 OpenAI Bots Took Part in Massive Hacking Attack
ICE arrests explode as Trump hands cops sweeping new powers...
Singapore is experimenting with biological computing using living human neurons...
It's Happening - Europe is Building an Impossible Fusion Reactor
Portable 1MW Kaleidos Microreactor Secures Critical Nuclear Fuel Deal Through 2030s
This New All-In-One Range Extender Is Ready To Go Into Any Electric Truck
Aptera Reveals The Secret To Building Its Solar EV: China
High-voltage sodium home battery emerges as affordable rooftop solar solution
Peter Thiel-Funded Company Anduril to Triple the Number of Autonomous Surveillance...
China has released Origin Pilot, claimed to be the world's first open-source operating system...
ShieldAI XBAT Drone Fighters Can Give A Fighter Drone Wing to Every US Destroyer
Brain organoids, kept alive more than five years, matured like human brains
Scientists from the Salk Institute say the safe and effective technique works by partially resetting cells that impact skin, eyesight, muscles, and the brain. The breakthrough may be able to extend life and help people gain the ability to become more resistant to stress, injury, and disease.
While it may appear to be the Holy Grail of anti-aging research, promising eternal youth, the team cautions that they've only successfully tested the treatment on mice so far. Animals at the late stage of their lives treated with cellular rejuvenation therapy started to show signs of getting younger after just seven months.
New tests are now underway to determine whether the treatment only "pauses" or actually reverses aging. In the study, the researchers note that all cells carry a molecular clock that records the passage of time. By adding a mixture of four reprogramming molecules, known as the Yamanaka factors, the cells reset the clock to their original patterns.
Turning back the clock in less than a year?
The scientists tested three groups of mice at varying ages equivalent to humans being 35, 50, and 80 years-old (12 months, 15 months, and 25 months in mice). There were no blood cell alterations or neurological changes in the mice that received the treatment. The team also found no cancers in any of the groups.